# Serum Collection Study for Assay Development

> **NCT07205289** · PHASE1 · RECRUITING · sponsor: **GPN Vaccines** · enrollment: 12 (estimated)

## Conditions studied

- Pneumococcal Disease, Invasive
- Pneumococcal Disease

## Interventions

- **BIOLOGICAL:** Gamma-PN

## Key facts

- **NCT ID:** NCT07205289
- **Lead sponsor:** GPN Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2026-01
- **Final completion:** 2026-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07205289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07205289, "Serum Collection Study for Assay Development". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07205289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*